IL-1β, IL-4 and IL-12 control the fate of group 2 innate lymphoid cells in human airway inflammation in the lungs. (Q53793238)

19 May 2018

title

IL-1β, IL-4 and IL-12 control the fate of group 2 innate lymphoid cells in human airway inflammation in the lungs. (English)

1 reference

19 May 2018

author

Suzanne Bal

1

1 reference

19 May 2018

Jonas S Erjefält

15

1 reference

19 May 2018

Hergen Spits

16

object named as

Hergen Spits

1 reference

19 May 2018

author name string

Jochem H Bernink

2

1 reference

19 May 2018

Maho Nagasawa

3

1 reference

19 May 2018

Jelle Groot

4

1 reference

19 May 2018

Medya M Shikhagaie

5

1 reference

19 May 2018

Kornel Golebski

6

1 reference

19 May 2018

Cornelis M van Drunen

7

1 reference

19 May 2018

Rene Lutter

8

1 reference

19 May 2018

Rene E Jonkers

9

1 reference

19 May 2018

Pleun Hombrink

10

1 reference

19 May 2018

Melanie Bruchard

11

1 reference

19 May 2018

Julien Villaudy

12

1 reference

19 May 2018

J Marius Munneke

13

1 reference

19 May 2018

Wytske Fokkens

14

1 reference

19 May 2018

Xavier Romero Ros

17

1 reference

19 May 2018

language of work or name

English

0 references

publication date

25 April 2016

1 reference

19 May 2018

published in

Nature Immunology

1 reference

19 May 2018

volume

17

1 reference

19 May 2018

issue

6

1 reference

19 May 2018

page(s)

636-645

1 reference

19 May 2018

Immunology of asthma and chronic obstructive pulmonary disease

cites work

1 reference

Pathogenesis of nasal polyposis

21 January 2018

1 reference

Thymic stromal lymphopoietin activity is increased in nasal polyps of patients with chronic rhinosinusitis

21 January 2018

1 reference

Treatment-recalcitrant chronic rhinosinusitis with polyps is associated with altered epithelial cell expression of interleukin-33.

21 January 2018

1 reference

The cytokine network in chronic obstructive pulmonary disease

21 January 2018

1 reference

Cigarette smoke silences innate lymphoid cell function and facilitates an exacerbated type I interleukin-33-dependent response to infection.

21 January 2018

1 reference

The role of airway epithelial cells and innate immune cells in chronic respiratory disease

21 January 2018

1 reference

Innate lymphoid cells in inflammation and immunity

21 January 2018

1 reference

The biology of innate lymphoid cells

21 January 2018

1 reference

Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology.

21 January 2018

1 reference

A T-bet gradient controls the fate and function of CCR6-RORγt+ innate lymphoid cells

21 January 2018

1 reference

Enhanced innate type 2 immune response in peripheral blood from patients with asthma

21 January 2018

1 reference

A role for IL-25 and IL-33-driven type-2 innate lymphoid cells in atopic dermatitis.

21 January 2018

1 reference

Composition of innate lymphoid cell subsets in the human skin: enrichment of NCR(+) ILC3 in lesional skin and blood of psoriasis patients.

21 January 2018

1 reference

Interleukin-17-producing innate lymphoid cells and the NLRP3 inflammasome facilitate obesity-associated airway hyperreactivity

21 January 2018

1 reference

Tissue residency of innate lymphoid cells in lymphoid and nonlymphoid organs

21 January 2018

1 reference

Regulated expression of nuclear receptor RORγt confers distinct functional fates to NK cell receptor-expressing RORγt(+) innate lymphocytes

21 January 2018

1 reference

Human innate lymphoid cells

21 January 2018

1 reference

Group 2 innate lymphoid cells in the regulation of immune responses.

21 January 2018

1 reference

Group 2 innate lymphoid cells promote beiging of white adipose tissue and limit obesity

21 January 2018

1 reference

The transcription factor GATA3 is essential for the function of human type 2 innate lymphoid cells

21 January 2018

1 reference

Monitoring the effect of gene silencing by RNA interference in human CD34+ cells injected into newborn RAG2-/- gammac-/- mice: functional inactivation of p53 in developing T cells.

21 January 2018

1 reference

Interleukin-1beta selectively expands and sustains interleukin-22+ immature human natural killer cells in secondary lymphoid tissue.

21 January 2018

1 reference

A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity

21 January 2018

1 reference

The role of Th1/Th2 polarization in mucosal immunity

21 January 2018

1 reference

Type 2 immunity reflects orchestrated recruitment of cells committed to IL-4 production

21 January 2018

1 reference

Tissue-resident natural killer (NK) cells are cell lineages distinct from thymic and conventional splenic NK cells

21 January 2018

1 reference

Therapeutic approaches to asthma-chronic obstructive pulmonary disease overlap syndromes.

21 January 2018

1 reference

Interleukin-33 and Interferon-γ Counter-Regulate Group 2 Innate Lymphoid Cell Activation during Immune Perturbation

21 January 2018

1 reference

Type 2 innate lymphoid cells control eosinophil homeostasis

21 January 2018

1 reference

IFN-γ synergistically enhances LPS signalling in alveolar macrophages from COPD patients and controls by corticosteroid-resistant STAT1 activation

21 January 2018

1 reference

Protective effects of basic fibroblast growth factor in the development of emphysema induced by interferon-γ

21 January 2018

1 reference

Effect of Subcutaneous Dupilumab on Nasal Polyp Burden in Patients With Chronic Sinusitis and Nasal Polyposis: A Randomized Clinical Trial

21 January 2018

1 reference

Dupilumab in persistent asthma with elevated eosinophil levels

21 January 2018

1 reference

Nasal IL-5 levels determine the response to anti-IL-5 treatment in patients with nasal polyps

21 January 2018

1 reference

Mepolizumab, a humanized anti-IL-5 mAb, as a treatment option for severe nasal polyposis

21 January 2018

1 reference

Lebrikizumab treatment in adults with asthma

21 January 2018

1 reference

Innate Immune Defenses Mediated by Two ILC Subsets Are Critical for Protection against Acute Clostridium difficile Infection

21 January 2018

1 reference

Inflammatory triggers associated with exacerbations of COPD orchestrate plasticity of group 2 innate lymphoid cells in the lungs

21 January 2018

1 reference

12 December 2020

Association between Group 2 Innate Lymphoid Cells enrichment, nasal polyps and allergy in Chronic Rhinosinusitis

1 reference

12 December 2020

Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues

1 reference

12 December 2020

Dupilumab treatment in adults with moderate-to-severe atopic dermatitis

1 reference

12 December 2020

Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161

1 reference

12 December 2020

Interleukin-12 and -23 Control Plasticity of CD127(+) Group 1 and Group 3 Innate Lymphoid Cells in the Intestinal Lamina Propria

1 reference

12 December 2020

Type 2 innate lymphoid cells in induced sputum from children with severe asthma

1 reference

12 December 2020

Fibroblast signal transducer and activator of transcription 4 drives cigarette smoke-induced airway fibrosis

1 reference

12 December 2020

Identifiers

DOI

10.1038/NI.3444

1 reference

19 May 2018

1 reference

19 May 2018